After an initial platform deal, private equity investors look for secondary, add-on deals that enhance their portfolios by filling gaps and building scale. Here are five things to know about follow-on deals.
CleanSlate's growth is driven by an emerging demand for medication-assisted treatment services as well as market opportunity. With backing from growth-equity fund Apple Tree Partners, the organization is primarily expanding through new center openings.
Treatment centers must weigh costs and clinical needs when creating policies for patient drug testing. Meanwhile, investors are examining how drug testing fits in the greater scheme of profits and regulatory risks.
Private equity investors are putting a great deal of time, effort and money into figuring out how to transform the behavioral healthcare industry, and our industry leaders must match that, in terms of time and effort, if not money.